Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)
Phase: PHASE2 | Sponsor: Centre Hospitalier St Anne | Compound: Psilocybin
- Status
- planned
- Institution
- Centre Hospitalier St Anne
- Start date
- 2025-10-08
- End date
- 2030-06-30
- Registry ID
- NCT07210112
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.